A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Drug Acquiring Popularity Online
The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering substances of unknown origin.
Some experts said the demand for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Platform Response and Material Removal
According to the social media company, the service has removed violative material and banned associated keywords and query recommendations. The company stated it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.
After minutes of entering one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these groups, posts display black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially serious health risks”.
